Nonobstructive Heart Enlargement Responds to Aficamten

122812



122812 (MedPage Today) — Treatment with aficamten (Myqorzo) improved exercise capacity as well as health status and symptoms in patients with symptomatic nonobstructive hypertrophic cardiomyopathy (HCM) in a large, double-blind, placebo-controlled trial…



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *